BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 10022468)

  • 1. A tandem repeat of MUC1 core protein induces a weak in vitro immune response in human B cells.
    Andersson E; Henderikx P; Krambovitis E; Hoogenboom HR; Borrebaeck CA
    Cancer Immunol Immunother; 1999 Jan; 47(5):249-56. PubMed ID: 10022468
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In vitro immunization of naive human B cells yields high affinity immunoglobulin G antibodies as illustrated by phage display.
    Dueñas M; Chin LT; Malmborg AC; Casalvilla R; Ohlin M; Borrebaeck CA
    Immunology; 1996 Sep; 89(1):1-7. PubMed ID: 8911132
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Generation of human anti-MUC3 IgG antibodies after in vitro immunization of naive peripheral blood B-lymphocytes.
    Baritaki S; Zafiropoulos A; Georgopoulos E; Souris S; Krambovitis E
    Cancer Immunol Immunother; 2001 Apr; 50(2):109-14. PubMed ID: 11401025
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Molecular characterization of the circulating anti-HIV-1 gp120-specific B cell repertoire using antibody phage display libraries generated from pre-selected HIV-1 gp120 binding PBLs.
    Koefoed K; Farnaes L; Wang M; Svejgaard A; Burton DR; Ditzel HJ
    J Immunol Methods; 2005 Feb; 297(1-2):187-201. PubMed ID: 15777942
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Isolation of MUC1-primed B lymphocytes from tumour-draining lymph nodes by immunomagnetic beads.
    Petrarca C; Casalino B; von Mensdorff-Pouilly S; Rughetti A; Rahimi H; Scambia G; Hilgers J; Frati L; Nuti M
    Cancer Immunol Immunother; 1999 Jan; 47(5):272-7. PubMed ID: 10022471
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Human single-chain Fv antibodies to MUC1 core peptide selected from phage display libraries recognize unique epitopes and predominantly bind adenocarcinoma.
    Henderikx P; Kandilogiannaki M; Petrarca C; von Mensdorff-Pouilly S; Hilgers JH; Krambovitis E; Arends JW; Hoogenboom HR
    Cancer Res; 1998 Oct; 58(19):4324-32. PubMed ID: 9766660
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Induction of antibody responses to breast carcinoma associated mucins using synthetic peptide constructs as immunogens.
    Denton G; Sekowski M; Price MR
    Cancer Lett; 1993 Jul; 70(3):143-50. PubMed ID: 7689035
    [TBL] [Abstract][Full Text] [Related]  

  • 8. T cells recognize PD(N/T)R motif common in a variable number of tandem repeat and degenerate repeat sequences of MUC1.
    Pisarev VM; Kinarsky L; Caffrey T; Hanisch FG; Sanderson S; Hollingsworth MA; Sherman S
    Int Immunopharmacol; 2005 Feb; 5(2):315-30. PubMed ID: 15652762
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mapping of B-cell determinants in the nucleocapsid protein of Puumala virus: definition of epitopes specific for acute immunoglobulin G recognition in humans.
    Lundkvist A; Björsten S; Niklasson B; Ahlborg N
    Clin Diagn Lab Immunol; 1995 Jan; 2(1):82-6. PubMed ID: 7536616
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Generation of monoclonal antibodies of desired specificity using chimeric polyomavirus-derived virus-like particles.
    Zvirbliene A; Samonskyte L; Gedvilaite A; Voronkova T; Ulrich R; Sasnauskas K
    J Immunol Methods; 2006 Apr; 311(1-2):57-70. PubMed ID: 16516908
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Presentation of HIV V3 loop epitopes for enhanced antigenicity, immunogenicity and diagnostic potential.
    Fontenot JD; VanCott TC; Parekh BS; Pau CP; George JR; Birx DL; Zolla-Pazner S; Gorny MK; Gatewood JM
    AIDS; 1995 Oct; 9(10):1121-9. PubMed ID: 8519447
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Humoral immunity against a tandem repeat epitope of human mucin MUC-1 in sera from breast, pancreatic, and colon cancer patients.
    Kotera Y; Fontenot JD; Pecher G; Metzgar RS; Finn OJ
    Cancer Res; 1994 Jun; 54(11):2856-60. PubMed ID: 7514493
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Products of Chemoenzymatic Synthesis Representing MUC1 Tandem Repeat Unit with T-, ST- or STn-antigen Revealed Distinct Specificities of Anti-MUC1 Antibodies.
    Yoshimura Y; Denda-Nagai K; Takahashi Y; Nagashima I; Shimizu H; Kishimoto T; Noji M; Shichino S; Chiba Y; Irimura T
    Sci Rep; 2019 Nov; 9(1):16641. PubMed ID: 31719620
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Peptide epitope binding and fluorescence quenching with the anti-mucin antibody C595.
    Scanlon MJ; Price MR; Tendler SJ
    Cancer Lett; 1992 Apr; 63(3):199-202. PubMed ID: 1374287
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of the efficiency of antibody selection from semi-synthetic scFv and non-immune Fab phage display libraries against protein targets for rapid development of diagnostic immunoassays.
    Chan CE; Chan AH; Lim AP; Hanson BJ
    J Immunol Methods; 2011 Oct; 373(1-2):79-88. PubMed ID: 21856306
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cassette vectors for conversion of Fab fragments into full-length human IgG1 monoclonal antibodies by expression in stably transformed insect cells.
    Guttieri MC; Sinha T; Bookwalter C; Liang M; Schmaljohn CS
    Hybrid Hybridomics; 2003 Jun; 22(3):135-45. PubMed ID: 12954098
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A human immunoglobulin G1 antibody originating from an in vitro-selected Fab phage antibody binds avidly to tumor-associated MUC1 and is efficiently internalized.
    Henderikx P; Coolen-van Neer N; Jacobs A; van der Linden E; Arends JW; Müllberg J; Hoogenboom HR
    Am J Pathol; 2002 May; 160(5):1597-608. PubMed ID: 12000712
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Chimeric rabbit/human Fab and IgG specific for members of the Nogo-66 receptor family selected for species cross-reactivity with an improved phage display vector.
    Hofer T; Tangkeangsirisin W; Kennedy MG; Mage RG; Raiker SJ; Venkatesh K; Lee H; Giger RJ; Rader C
    J Immunol Methods; 2007 Jan; 318(1-2):75-87. PubMed ID: 17140598
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Detection of a circulating antibody against a peptide epitope on a mucin core protein, MUC1, in ulcerative colitis.
    Hinoda Y; Nakagawa N; Nakamura H; Makiguchi Y; Itoh F; Adachi M; Yabana T; Imai K; Yachi A
    Immunol Lett; 1993 Feb; 35(2):163-8. PubMed ID: 7685318
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The production and characterization of novel heavy-chain antibodies against the tandem repeat region of MUC1 mucin.
    Rahbarizadeh F; Rasaee MJ; Forouzandeh M; Allameh A; Sarrami R; Nasiry H; Sadeghizadeh M
    Immunol Invest; 2005; 34(4):431-52. PubMed ID: 16302687
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.